m62A inhibited ADAM10 protein expression but not mRNA expression in H1975 (Figure 3A) and A549 (Figure 3B) lung cancer cell lines, and BT549 breast cancer cell line (Figure 3C) in a dosage-dependent manner. Here, ADAM10 is linked to lung carcinoma.